ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,448, issued on Dec. 30, was assigned to INVENTISBIO Co. LTD. (Shanghai).
"Salts of indoleamine 2,3-dioxygenase inhibitors" was invented by Xing Dai (Shanghai), Yueheng Jiang (Shanghai) and Yanqin Liu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to IDO inhibitors, in particular, Compound 1,1-(5-((4-chlorophenyl)amino)-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)pyridin-3-yl)cyclobutane-1-carboxylic acid. Also provided are methods of treating a disease or disorder such as a cancer or infectious disease that comprises administering to a sub...